LEMS Expert Webinars
Detailed clinical studies have improved our diagnostic skills and knowledge of the pathophysiological mechanisms of LEMS.
—Titulaer et al, 20114
Detailed clinical studies have improved our diagnostic skills and knowledge of the pathophysiological mechanisms of LEMS.
—Titulaer et al, 20114
Are my muscles aging?
One Often-Misdiagnosed Cause of Weakness and Fatigue
Mazen M. Dimachkie, MD
Professor | Executive Vice Chair
Neuromuscular Division Chief
University of Kansas Medical Center
Impact of LEMS in SCLC
The impact of Lambert-Eaton myasthenic syndrome (LEMS) on patients with small cell lung cancer
Corey L. Langer, MD, FACP
Professor
Director at the Abramson Cancer Center University of Pennsylvania
MORE LEMS WEBINAR CONTENT AVAILABLE NOW ON ONCLIVE®
Small Cell Lung Cancer and Lambert-Eaton Myasthenic Syndrome:
A Multichapter Review
Stephen Vernino, MD, PhD
Department of Neurology
UT Southwestern Medical Center
Dallas, Texas
David Gerber, MD
Division of Hematology/Oncology
UT Southwestern Medical Center
Dallas, Texas
EP. 1: Defining LEMS (Gerber)
EP. 2: Testing for LEMS (Vernino)
EP. 3: LEMS Case Review (Vernino)
EP. 4: LEMS Diagnosis: Patient Presentation and Testing (Gerber)
EP. 5: Front-line Treatment Options for SCLC (Gerber)
EP. 6: Treatment Options for LEMS (Vernino)
EP. 7: Monitoring Patients with SCLC and LEMS (Gerber)
EP. 8: Case Review: Small Cell Lung Cancer Following LEMS (Gerber)
EP. 9: Clinical Pearls and the Future of LEMS (Vernino)